Search ForexCrunch
  • S&P 500 Futures tread water amid mixed catalysts.
  • Brexit updates are the major contributors to the latest indecision.
  • Stimulus hopes, vaccine updates keep the traders hopeful.

S&P 500 Futures seesaw near 3,700, currently up 0.03% to 3,698.62, during the early Monday. The risk barometer closed at the record high of 3,700 on Friday but fails to extend the north-run afterward.

Although hopes of the US coronavirus (COVID-19) aid package joins chatters concerning further stimulus from the UK and Japan to keep the global traders optimistic, fears of hard Brexit probe the optimism.

With the downbeat prints of November Nonfarm Payrolls (NFP) from the US, 245K versus 610K in October, US policymakers are pushed for the much-awaited aid package. Latest updates suggest that the Senate members are looking forward towards the $908 billion package as the economic relief to combat the pandemic. However, political differences between the Republicans and Democrats delay the announcement.

While the recent updates from the Times suggest that Germany and France are likely to ease their demands to facilitate the Brexit talks, many obstacles challenge the successful Brexit deal negotiations going forward.

Elsewhere, the COVID-19 vaccines are just around the corner with Russia announcing the start of vaccination while the UK and the US remain in the pipeline.

It should be noted that the US-China tussle renews as the Trump administration announces fresh sanctions on the Beijing-based companies and some of the Communist Party members off-late. As per the latest news from Reuters, the Trump administration preparing new sanctions on at least a dozen Chinese officials over Beijing’s move to disqualify elected legislators in Hong Kong.

Against this backdrop, stocks in Asia-Pacific remain directionless while the US 10-year Treasury yields waver around 0.97% by press time.

Moving on, China’s November month trade numbers can offer immediate direction to markets but major attention will be given to the Brexit, stimulus and vaccine headlines for fresh impetus.